Christopher Edwards, Brian Drumm, James E Siegler, Wouter J Schonewille, Piers Klein, Xiaochuan Huo, Yimin Chen, Mohamad Abdalkader, Muhammad M Qureshi, Daniel Strbian, Xinfeng Liu, Wei Hu, Xunming Ji, Chuanhui Li, Urs Fischer, Simon Nagel, Volker Puetz, Patrik Michel, Fana Alemseged, Simona Sacco, Hiroshi Yamagami, Shadi Yaghi, Davide Strambo, Espen Saxhaug Kristoffersen, Else C Sandset, Robert Mikulik, Georgios Tsivgoulis, Hesham E Masoud, Diana Aguiar de Sousa, João Pedro Marto, Kyriakos Lobotesis, Dylan Roi, Anne Berberich, Jelle Demeestere, Thomas R Meinel, Rodrigo Rivera, Sven Poli, Mai Duy Ton, Yuyou Zhu, Fengli Li, Hongfei Sang, Götz Thomalla, Mark Parsons, Bruce C V Campbell, Osama O Zaidat, Hui-Sheng Chen, Thalia S Field, Jean Raymond, Johannes Kaesmacher, Raul G Nogueira, Tudor G Jovin, Dapeng Sun, Raynald Liu, Adnan I Qureshi, Zhongming Qiu, Zhongrong Miao, Soma Banerjee, Thanh N Nguyen
BACKGROUND AND PURPOSE: Two early basilar artery occlusion (BAO) randomized controlled trials did not establish the superiority of endovascular thrombectomy (EVT) over medical management. While many providers continue to recommend EVT for acute BAO, perceptions of equipoise in randomizing patients with BAO to EVT versus medical management may differ between clinician specialties. METHODS: We conducted an international survey (January 18, 2022 to March 31, 2022) regarding management strategies in acute BAO prior to the announcement of two trials indicating the superiority of EVT, and compared responses between interventionalists (INTs) and non-interventionalists (nINTs)...
February 13, 2023: Journal of Neuroimaging: Official Journal of the American Society of Neuroimaging